Bizarre Patents
Dining Table Having Integral Dishwasher
A space-saving dishwasher, which may be installed within a counter top or table, having a dish-carrying rack that is vertically shiftable through the open top of the dishwasher for facilitating loading and unloading of the dishes.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188035 | Method for using nano carbon to refine collagen into nanoparticulate collagen This invention relates to a method of using nano carbon to refine collagen into nanoparticulate collagen. As nano carbon particle are mixed into collagen, the pored structure of the nano carbon absorb and adhere to the collagen outer cell membrane and subsequently t... | 05/29/2012 |
| 8173599 | Spray-dried collectin compositions and process for preparing the same The present invention relates to a spray-dried composition comprising as an active ingredient at least one member protein of the collectin family or its functional equivalent for treating and preventing microbial infectious diseases. The present invention also relat... | 05/08/2012 |
| 8168587 | Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases This invention provides various combinations of enzyme replacement therapy, gene therapy, and small molecule therapy for the treatment of lysosomal storage diseases. ... | 05/01/2012 |
| 8163692 | Protection against and treatment of ionizing radiation Methods of preparing a proteoliposome comprise the step of contacting a liposome with an effective portion of RalBP1 to create a proteoliposome. RalBP1 is effective for the protection and treatment of mammals and the environment against the accumulation of toxic com... | 04/24/2012 |
| 8148324 | Chemoenzymatic methods for the synthesis of statins and statin intermediates The invention provides aldolases, nucleic acids encoding them and methods for making and using them, including chemoenzymatic processes for making β,δ-dihydroxyheptanoic acid side chains and compositions comprising these side chains, e.g., [R—(R*,R*)]-2-(4-fluor... | 04/03/2012 |
| 8138144 | Antimicrobial cationic peptides and formulations thereof Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections ma... | 03/20/2012 |
| 8129351 | Immunostimulatory nucleic acid molecules Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atop... | 03/06/2012 |
| 8124588 | Chimeric plasminogen activators and their pharmaceutical use The present invention relates to recombinant chimeric proteins comprising a surfactant protein precursor N-terminally fused to a plasminogen activator or comprising a mature surfactant protein N-terminally or C-terminally fused to a plasminogen activator. The invent... | 02/28/2012 |
| 8124581 | Methods for treating breast cancer using NRIF3 related molecules Disclosed herein is the discovery that administration of the NRIF3 family of transcriptional coregulators (NRIF3 and related molecules) to breast cancer cells induce rapid and profound apoptosis (nearly 100% cell death within 24 h). A novel death domain (DD1) was ma... | 02/28/2012 |
| 8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in ... | 02/14/2012 |
| 8114832 | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition The invention relates to the detection and/or removal of conformationally altered proteins and/or molecules comprising a cross-β structure from a pharmaceutical composition. Disclosed is that unwanted and/or toxic side effects of pharmaceuticals are caused by prote... | 02/14/2012 |
| 8114843 | Photoreactive regulator of protein function and methods of use thereof The present invention provides a synthetic regulator of protein function, which regulator is a light-sensitive regulator. The present invention further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and me... | 02/14/2012 |
| 8110544 | RasGAP derived peptide for selectively killing cancer cells The present invention relates to a peptide consisting in the N2 sequence of the RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition comprisin... | 02/07/2012 |
| 8106005 | Modulating apoptosis The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-κB activity. The modulators may be used, for example, in the treatment of NF-κB-mediated diseases, conditions, and injuries. ... | 01/31/2012 |
| 8106004 | Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived ... | 01/31/2012 |
| 8101566 | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis A method of suppressing angiogenesis in a mammal (e.g., for treating tumors, tumor metastasis or a condition that would benefit from decreased angiogenesis) comprises the step of administering to the mammal an angiostatically effective amount of a pharmaceutical com... | 01/24/2012 |
| 8101565 | Sustained release of Apo A-I mimetic peptides and methods of treatment A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall... | 01/24/2012 |
| 8097583 | Proteins of natural origin and materials made therefrom The present invention is directed to proteins of natural origin and materials made therefrom, in particular to threads, fibers, foams and gels derived therefrom. The invention further provides the use of these proteins/threads and materials in the field of technolog... | 01/17/2012 |
| 8088728 | Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of natural anticoagulants to a subject via airway administration to... | 01/03/2012 |
| 8084434 | Runx2 isoforms in angiogenesis The present invention relates to RUNX2 and RUNXdelta8, and their use in modulating conditions and diseases associated with angiogenesis and cell proliferation. For example, RUNX2delta8 can be utilized to inhibit tumor growth and to prevent or inhibit angiogenesis. T... | 12/27/2011 |
| 8084415 | Uteroglobin in the treatment of IGA mediated nephropathy Uteroglobin has been discovered to prevent IgA mediated diseases, such as IgA nephropathy, by preventing the deposition of IgA-Fibronectin immunocomplexes in tissues such as the renal glomeruli. The invention therefore includes methods of treating such diseases by a... | 12/27/2011 |
| 8084416 | AXMI-150 delta-endotoxin gene and methods for its use Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions including a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or exp... | 12/27/2011 |
| 8076282 | Composition for improving membrane composition and functioning of cells It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a/ a lipid fraction comprising at least one of docosahexanoic aci... | 12/13/2011 |
| 8076283 | Methods for treating congestive heart failure The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene. ... | 12/13/2011 |
| 8071539 | Albumin fusion proteins The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic ac... | 12/06/2011 |
| 8063014 | Self-assembly of peptide-amphiphile nanofibers under physiological conditions The present invention provides a method of promoting neuron growth and development by contacting cells with a peptide amphiphile molecule in an aqueous solution in the presence of a metal ion. According to the method, the peptide amphiphile forms a cylindrical micel... | 11/22/2011 |
| 8058234 | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease The present invention relates to methods of using lactoferrin (LF) to treat, prevent or reduce the incidence of organ transplant rejection and graft-versus-host-disease. More particularly, the present invention relates to methods of reducing an immune response again... | 11/15/2011 |
| 8058233 | Modification of feeding behavior using PYY and GLP-1 Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering PYY or an agonist thereof and GLP-1 or an agonist thereof to the subject, simultaneously or sequentially, thereby decreasing t... | 11/15/2011 |
| 8058235 | Water-mediated control of depolymerization step of glatiramer acetate synthesis Methods of making copolymers are described. ... | 11/15/2011 |
| 8044021 | Sustained release of apo A-I mimetic peptides and methods of treatment A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall... | 10/25/2011 |
| 8034764 | Modulation of SOCS expression in therapeutic regimens A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein certain physiological processes normally associated with cytokine administration (e.g. the induction of SOCS 1 and/or SOCS 3) are diminished or eliminated. The met... | 10/11/2011 |
| 8034765 | Compositions and methods for preparation of poorly water soluble drugs with increased stability The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle ... | 10/11/2011 |
| 8034766 | Compositions and methods for prion decontamination The invention relates to compositions and methods for prion degradation, decontamination or disinfection. The composition comprises an oxidizing agent, one or more proteases and a surfactant such as an ionic surfactant/detergent. The method comprises contacting a pr... | 10/11/2011 |
| 8034767 | Method for producing purine nucleosides and nucleotides by fermentation using a bacterium belonging to the genus or A method is provided for producing a purine nucleoside, such as inosine and guanosine, and a method for producing a 5′-purine nucleotide such as 5′-inosinic acid or 5′-guanylic acid, using a bacterium belonging to the either genus Escherichia or genus | 10/11/2011 |
| 8030277 | Polypeptide and gene encoding the same A polypeptide having the amino acid sequence as set forth in SEQ ID NO: 2, 4, or 6, a DNA encoding the same, and an antibody against said polypeptide, and the use thereof. The above amino acid sequence has a homology with chondromodulin-I that has an effect of contr... | 10/04/2011 |
| 8012929 | Peptides directed for diagnosis and treatment of amyloid-associated diseases Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions a... | 09/06/2011 |
| 8008248 | Modified Cry3A toxins and nucleic acid sequences coding therefor Methods for making a modified Cry3A toxin are disclosed. Such methods include the insertion of a protease recognition site that is recognized by a gut protease of a target insect, such as corn rootworm, into at least one position of a Cry3A toxin so that a modified ... | 08/30/2011 |
| 8008249 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration Neuregulin, a known neuroprotein, has been found to ameliorate or prevent damage caused by mechanical or chemical assault to blood vessels and, when administered into the cerebral spinal fluid, can ameliorate damage to neuronal tissue caused by stroke or inflammatio... | 08/30/2011 |
| 8003600 | Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies It has been found that high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, especially in relative absence of glutamate equivalents, improve the metabolism of ketobodies and/or lactate in a mammal's body, especially in diseased or tra... | 08/23/2011 |
| 7998925 | Spatially-defined modification of fresh tissue using covalent chemistry Methods for modification of tissue using covalent chemistry. Tissue can be modified through direct alkylation, reduction followed by alkylation, or oxidation followed by condensation to covalently attach small organic molecules or appropriately modified proteins. Th... | 08/16/2011 |
